Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. II: Tissue distribution and pharmacodynamics

International Journal of Pharmaceutics

Volumn 307, Issue 2, 2006, Pages 175-181

  Lu, Bin ^a   Xiong, Su Bin ^a   Yang, Hong ^a   Yin, Xiao Dong ^a   Zhao, Ruo Bing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Bovine serum albumin; Breast cancer; Chitosan; Lymph node metastases; Mitoxantrone; Nanospheres; Site specific delivery

Indexed keywords

BOVINE SERUM ALBUMIN; CHITOSAN; MITOXANTRONE; NANOPARTICLE;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL STRAIN MCF 7; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; EVALUATION; INJECTION; LEUKEMIA P 388; LEUKOCYTE COUNT; LIVER TOXICITY; LUNG TOXICITY; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ACUTE TOXICITY TESTS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; FEMALE; HUMANS; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOXANTRONE; NANOSTRUCTURES; NEOPLASM TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN, BOVINE; TISSUE DISTRIBUTION;

EID: 29244446015     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.09.038     Document Type: Article

References (10)

1. T.B. Bevers Breast cancer chemoprevention: current clinical practice and future direction Biomed. Pharmacother. 55 2001 559 564
2. H. Chamras, A. Ardashian, D. Heber, and J.A. Glasy Fattic acid modulation of human MCF-7 breast cancer cell proliferation, apoptosis and differentiation J. Nutr. Biochem. 13 2002 711 716
3. A. Hagiwara, T. Takahashi, and K. Sawai Methotrexate bound to carbon particles used for treating cancers with lymph node metastases in animal experiments and a clinical pilot study Cancer 78 1996 2199 2209
4. O.Y.P. Hu Novel assay method for mitoxantrone in plasma and its application in cancer patients J. Chromatogr. 532 1990 337 350
5. A. Kata, Y. Takakura, and M. Hashida Physico-chemical and antitumor characteristics of high molecular weight prodrugs of mitomycin Chem. Pharm. Bull. 36 1982 2951 2957
6. S.L. Li Oncology of Mammary Gland 2000 Publishing House of Science and Technology Beijing 1 134
7. C. Oussoren, W.M.C. Eling, and D.J.A. Crommelin The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue local toxicity of two antitumor drugs Biochim. Biophys. Acta 1369 1998 159 172
8. W.T. Phillips, R.K. lipper, and B. Goins Novel method of greatly enhanced delivery of liposomes to lymph nodes J. Parmacol. Exp. Ther. 295 2000 309 313
9. K.M. Rentsch, R.A. Schwendener, and E. Haeseler Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatography J. Chromatogr. 679 1996 185 192
10. M. Schaich, T. Illmer, and W. Aulitzky Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukaemia patients aged 61-65 years Haematologica 87 2002 808 815